T45.6
Poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code T45.6 covers cases of poisoning, adverse effects, or underdosing related to drugs that influence the process of fibrinolysis—the body’s way of breaking down blood clots. Fibrinolytic agents are commonly used in medical settings to dissolve clots and treat conditions such as strokes or heart attacks. While these drugs can be life-saving, they also carry risks of complications if not used properly.
Causes & Symptoms
Clinical Causes: Unintentional overdose of fibrinolytic drugs Accidental ingestion or misuse Incorrect administration or dosing errors in healthcare settings Adverse reactions to fibrinolytic therapy Drug interactions leading to enhanced or diminished effects
Key Symptoms: Bleeding or hemorrhage, which can be severe Unusual bruising or pinpoint red spots on the skin (petechiae) Signs of internal bleeding such as abdominal pain, dizziness, or weakness Reactions like allergic responses including rash, itching, or swelling Difficulty breathing in cases of serious allergic or adverse reactions
Diagnostic & Treatment
Diagnosis Path: Diagnosing poisoning or adverse effects from fibrinolytic drugs involves a combination of patient history, medication review, physical examination, and laboratory tests. Blood tests may reveal coagulation abnormalities, low platelet count, or other indicators of bleeding or drug toxicity. Imaging studies could be necessary if internal bleeding is suspected. The healthcare provider will evaluate for signs of overdose or adverse reaction and may adjust treatment protocols accordingly.
Treatment Protocols: Discontinuation or reversal of the fibrinolytic drug if possible Administering medications such as blood products, clotting factors, or antifibrinolytic agents to promote clotting Supportive care, including intravenous fluids and oxygen therapy Close monitoring of vital signs and laboratory parameters In severe cases, surgical interventions might be necessary to repair bleeding sources Ensuring proper dosing and administration practices in future treatments
Clinical Advice & FAQs
Billing Guidance
Is T45.6 a billable ICD-10 code?
Yes, T45.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.6?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference